Science of cancer and aging

Journal of Clinical Oncology

Volumn 25, Issue 14, 2007, Pages 1844-1851

  Irminger Finger, Irmgard ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; FREE RADICAL; REACTIVE OXYGEN METABOLITE;

AGING; APOPTOSIS; CALORIC RESTRICTION; CANCER INHIBITION; CANCER RESEARCH; CANCER STEM CELL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DNA DAMAGE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; LONGEVITY; MITOCHONDRION; MITOSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGERIA; REVIEW; GENETICS; METABOLISM; MUTATION; NEOPLASM; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; TELOMERE;

AGING; APOPTOSIS; CALORIC RESTRICTION; FREE RADICALS; HUMANS; MITOCHONDRIA; MUTATION; NEOPLASMS; PROGERIA; REACTIVE OXYGEN SPECIES; RISK FACTORS; TELOMERE;

EID: 34249781197     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.10.8928     Document Type: Review

References (127)

1. Peto R, Parish SE, Gray RG: There is no such thing as ageing, and cancer is not related to it. IARC Sci Publ:43-53, 1985
2. Peto R, Doll R: There is no such thing as aging. Bmj 315:1030-1032, 1997
3. DePinho RA: The age of cancer. Nature 408:248-254, 2000
4. Ramsey MR, Sharpless NE: ROS as a tumour suppressor? Nat Cell Biol 8:1213-1215, 2006
5. Langen RC, Korn SH, Wouters EF: ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 35:226-235, 2003
6. Song YS, Lee BY, Hwang ES: Distinct ROS and biochemical profiles in cells undergoing DNA damage-induced senescence and apoptosis. Mech Ageing Dev 126:580-590, 2005
7. Yanase S, Yasuda K, Ishii N: Adaptive responses to oxidative damage in three mutants of Caenorhabditis elegans (age-1, mev-1 and daf-16) that affect life span. Mech Ageing Dev 123:1579-1587, 2002
8. Dorman JB, Albinder B, Shroyer T, et al: The age-1 and daf-2 genes function in a common pathway to control the lifespan of Caenorhabditis elegans. Genetics 141:1399-1406, 1995
9. Malone EA, Inoue T, Thomas JH: Genetic analysis of the roles of daf-28 and age-1 in regulating Caenorhabditis elegans dauer formation. Genetics 143:1193-1205, 1996
10. Mockett RJ, Orr WC, Rahmandar JJ, et al: Antioxidant status and stress resistance in long- and short-lived lines of Drosophila melanogaster. Exp Gerontol 36:441-463, 2001
11. Missirlis F, Phillips JP, Jackle H: Cooperative action of antioxidant defense systems in Drosophila. Curr Biol 11:1272-1277, 2001
12. Lee AC, Fenster BE, Ito H, et al: Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274:7936-7940, 1999
13. Yuan H, Kaneko T, Matsuo M: Relevance of oxidative stress to the limited replicative capacity of cultured human diploid cells: The limit of cumulative population doublings increases under low concentrations of oxygen and decreases in response to aminotriazole. Mech Ageing Dev 81:159-168, 1995
14. Nevo Z, Beit-Or A, Eilam Y: Slowing down aging of cultured embryonal chick chondrocytes by maintenance under lowered oxygen tension. Mech Ageing Dev 45:157-165, 1988
15. Singh KK: Mitochondria damage checkpoint, aging, and cancer. Ann N Y Acad Sci 1067:182-190, 2006
16. Kowald A: The mitochondrial theory of aging: Do damaged mitochondria accumulate by delayed degradation? Exp Gerontol 34:605-612, 1999
17. Orr WC, Arnold LA, Sohal RS: Relationship between catalase activity, life span and some parameters associated with antioxidant defenses in Drosophila melanogaster. Mech Ageing Dev 63:287-296, 1992
18. Lin YJ, Seroude L, Benzer S: Extended lifespan and stress resistance in the Drosophila mutant methuselah. Science 282:943-946, 1998
19. Kabil H, Partridge L, Harshman LG: Superoxide dismutase activities in long-lived Drosophila melanogaster females: Chico (1) genotypes and dietary dilution. Biogerontology 2006
20. Ishii N: The role of stress in ageing: Research on the nematode, Caenorhabditis elegans. Br J Dermatol 153:1-5, 2005 (suppl 2)
21. Houthoofd K, Braeckman BP, Johnson TE, et al: Extending life-span in C. elegans. Science 305:1238-1239, 2004
22. Munoz MJ, Riddle DL: Positive selection of Caenorhabditis elegans mutants with increased stress resistance and longevity. Genetics 163:171-180, 2003
23. Tirosh O, Pardo M, Schwartz B, et al: Long-lived alphaMUPA transgenic mice show reduced SOD2 expression, enhanced apoptosis and reduced susceptibility to the carcinogen dimethylhydrazine. Mech Ageing Dev 126:1262-1273, 2005
24. Rhodes D, Giraldo R: Telomere structure and function. Curr Opin Struct Biol 5:311-322, 1995
25. Price CM: Telomere structure and function. Indian J Biochem Biophys 30:77-82, 1993
26. Allsopp RC, Chang E, Kashefi-Aazam M, et al: Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220:194-200, 1995
27. Hayflick L: The cell biology of aging. Clin Geriatr Med 1:15-27, 1985
28. Kajstura J, Pertoldi B, Leri A, et al: Telomere shortening is an in vivo marker of myocyte replication and aging. Am J Pathol 156:813-819, 2000
29. Artandi SE, DePinho RA: Mice without telomerase: What can they teach us about human cancer? Nat Med 6:852-855, 2000
30. Ferron S, Mira H, Franco S, et al: Telomere shortening and chromosomal instability abrogates proliferation of adult but not embryonic neural stem cells. Development 131:4059-4070, 2004
31. Metcalfe JA, Parkhill J, Campbell L, et al: Accelerated telomere shortening in ataxia telangiectasia. Nat Genet 13:350-353, 1996
32. Greenberg RA, Allsopp RC, Chin L, et al: Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16:1723-1730, 1998
33. de Lange T, DePinho RA: Unlimited mileage from telomerase? Science 283:947-949, 1999
34. Allsopp RC, Morin GB, DePinho R, et al: Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102:517-520, 2003
35. Artandi SE, Alson S, Tietze MK, et al: Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci U S A 99:8191-8196, 2002
36. Ahmed A, Tollefsbol TO: Telomerase, telomerase inhibition, and cancer. J Anti Aging Med 6:315-325, 2003
37. Cunningham AP, Love WK, Zhang RW, et al: Telomerase inhibition in cancer therapeutics: Molecular-based approaches. Curr Med Chem 13:2875-2888, 2006
38. Sharpless NE, DePinho RA: Telomeres, stem cells, senescence, and cancer. J Clin Invest 113:160-168, 2004
39. Zhang H: Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging. J Cell Physiol 210:567-574, 2007
40. Campisi J, Kim SH, Lim CS, et al: Cellular senescence, cancer and aging: The telomere connection. Exp Gerontol 36:1619-1637, 2001
41. Opitz OG: Telomeres, telomerase and malignant transformation. Curr Mol Med 5:219-226, 2005
42. MacKenzie KL, Franco S, Naiyer AJ, et al: Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene 21:4200-4211, 2002
43. Oexle K, Zwirner A: Advanced telomere shortening in respiratory chain disorders. Hum Mol Genet 6:905-908, 1997
44. Kawanishi S, Oikawa S: Mechanism of telomere shortening by oxidative stress. Ann N Y Acad Sci 1019:278-284, 2004
45. Oikawa S, Kawanishi S: Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 453:365-368, 1999
46. von Zglinicki T, Pilger R, Sitte N: Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic Biol Med 28:64-74, 2000
47. Coppe JP, Kauser K, Campisi J, et al: Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem 281:29568-29574, 2006
48. Itahana K, Dimri G, Campisi J: Regulation of cellular senescence by p53. Eur J Biochem 268:2784-2791, 2001
49. Campisi J: Analysis of tumor suppressor gene-induced senescence. Methods Mol Biol 223:155-172, 2003
50. Campisi J: Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 11:S27-31, 2001
51. Amundson SA, Myers TG, Fornace AJ Jr: Roles for p53 in growth arrest and apoptosis: Putting on the brakes after genotoxic stress. Oncogene 17:3287-3299, 1998
52. Jiang H, Luo S, Li H: Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint. J Biol Chem 280:20651-20659, 2005
53. Zhang X, Mar V, Zhou W, et al: Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 13:2388-2399, 1999
54. Rizo A, Vellenga E, de Haan G, et al: Signaling pathways in self-renewing hematopoietic and leukemic stem cells: Do all stem cells need a niche? Hum Mol Genet 15:R210-R219, 2006
55. Kari C, Chan TO, Rocha de Quadras M, et al: Targeting the epidermal growth factor receptor in cancer: Apoptosis takes center stage. Cancer Res 63:1-5, 2003
56. Smith KJ, Diwan H, Skelton H: Death receptors and their role in dermatology, with particular focus on tumor necrosis factor-related apoptosis-inducing ligand receptors. Int J Dermatol 42:3-17, 2003
57. Watters D: Molecular mechanisms of ionizing radiation-induced apoptosis. Immunol Cell Biol 77:263-271, 1999
58. Feng L, Hollstein M, Xu Y: Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence. Cell Cycle 5:2812-2819, 2006
59. Feki A, Jefford CE, Berardi P, et al: BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase. Oncogene 24:3726-3736, 2005
60. Chao C, Herr D, Chun J, et al: Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression. Embo J 25:2615-2622, 2006
61. Yin Y, Stephen CW, Luciani MG, et al: p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat Cell Biol 4:462-467, 2002
62. Kubbutat MH, Jones SN, Vousden KH: Regulation of p53 stability by Mdm2. Nature 387:299-303, 1997
63. Megyesi J, Udvarhelyi N, Safirstein RL, et al: The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol 271:F1211-F1216, 1996
64. Yamaguchi H, Chen J, Bhalla K, et al: Regulation of Bax activation and apoptotic response to microtubule-damaging agents by p53 transcription-dependent and -independent pathways. J Biol Chem 279:39431-39437, 2004
65. Moll UM, Zaika A: Nuclear and mitochondrial apoptotic pathways of p53. FEBS Lett 493:65-69, 2001
66. Kaneshiro K, Tsutsumi S, Tsuji S, et al: An integrated map of p53-binding sites and histone modification in the human ENCODE regions. Genomics 89:178-188, 2007
67. Miller RA, Harper JM, Galecki A, et al: Big mice die young: Early life body weight predicts longevity in genetically heterogeneous mice. Aging Cell 1:22-29, 2002
68. Murakami S, Salmon A, Miller RA: Multiplex stress resistance in cells from long-lived dwarf mice. Faseb J 17:1565-1566, 2003
69. Holzenberger M, Dupont J, Ducos B, et al: IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421:182-187, 2003
70. Pinkston JM, Garigan D, Hansen M, et al: Mutations that increase the life span of C. elegans inhibit tumor growth. Science 313:971-975, 2006
71. Finch CE, Ruvkun G: The genetics of aging. Annu Rev Genomics Hum Genet 2:435-462, 2001
72. Finch CE, Tanzi RE: Genetics of aging. Science 278:407-411, 1997
73. Longo VD, Finch CE: Evolutionary medicine: From dwarf model systems to healthy centenarians? Science 299:1342-1346, 2003
74. Clancy DJ, Gems D, Harshman LG, et al: Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292:104-106, 2001
75. Matyash V, Entchev EV, Mende F, et al: Sterol-derived hormone (s) controls entry into diapause in Caenorhabditis elegans by consecutive activation of DAF-12 and DAF-16. PLoS Biol 2:e280, 2004
76. Powers RW 3rd, Harrison DE, Flurkey K: Pituitary removal in adult mice increases life span. Mech Ageing Dev 127:658-659, 2006
77. Kirkwood TB: p53 and ageing: Too much of a good thing? Bioessays 24:577-579, 2002
78. Yu CE, Oshima J, Fu YH, et al: Positional cloning of the Werner's syndrome gene. Science 272:258-262, 1996
79. Matsumoto T, Shimamoto A, Goto M, et al: Impaired nuclear localization of defective DNA helicases in Werner's syndrome. Nat Genet 16:335-336, 1997
80. Stobetskii VI, Chebotarev AN, Kuleshov NP, et al: Chromosomal abnormalities in lymphocytes from a patient with Werner's syndrome in intact culture and after treatment with halogenated analogs of thymidine [Russian]. Tsitologiia 44:84-88, 2002
81. Hasenmaile S, Pawelec G, Wagner W: A lack of telomenc non-reciprocal recombination (TENOR) may account for the premature proliferation blockade of Werner's syndrome fibroblasts. Biogerontology 4:253-273, 2003
82. James SE, Faragher RG, Burke JF, et al: Werner's syndrome T lymphocytes display a normal in vitro life-span. Mech Ageing Dev 121:139-149, 2000
83. Ostler EL, Wallis CV, Sheerin AN, et al: A model for the phenotypic presentation of Werner's syndrome. Exp Gerontol 37:285-292, 2002
84. Watt PM, Hickson ID, Borts RH, et al: SGS1, a homologue of the Bloom's and Werner's syndrome genes, is required for maintenance of genome stability in Saccharomyces cerevisiae. Genetics 144:935-945, 1996
85. Yamagata K, Kato J, Shimamoto A, et al: Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast SGS1 mutant: Implication for genomic instability in human diseases. Proc Natl Acad Sci U S A 95:8733-8738, 1998
86. Bohr VA: Human premature aging syndromes and genomic instability. Mech Ageing Dev 123:987-993, 2002
87. Mohaghegh P, Hickson ID: Premature aging in RecQ helicase-deficient human syndromes. Int J Biochem Cell Biol 34:1496-1501, 2002
88. Chang S: Modeling premature aging syndromes with the telomerase knockout mouse. Curr Mol Med 5:153-158, 2005
89. Loke KY: Cockayne syndrome: A case report, and a review of the premature aging syndromes in paediatrics. J Singapore Paediatr Soc 33:49-54, 1991
90. Beauregard S, Gilchrest BA: Syndromes of premature aging. Dermatol Clin 5:109-121, 1987
91. Puzianowska-Kuznicka M, Kuznicki J: Genetic alterations in accelerated ageing syndromes. Do they play a role in natural ageing? Int J Biochem Cell Biol 37:947-960, 2005
92. Niemi AK, Moilanen JS, Tanaka M, et al: A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. Eur J Hum Genet 13:166-170, 2005
93. Parsons PA: Inherited stress resistance and longevity: A stress theory of ageing. Heredity 75:216-221, 1995
94. Gudmundsson H, Gudbjartsson DF, Frigge M, et al: Inheritance of human longevity in Iceland. Eur J Hum Genet 8:743-749, 2000
95. Henon N, Busson M, Dehay-Martuchou C, et al: Familial versus sporadic longevity and MHC markers. J Biol Regul Homeost Agents 13:27-31, 1999
96. Lao JI, Montoriol C, Morer I, et al: Genetic contribution to aging: Deleterious and helpful genes define life expectancy. Ann N Y Acad Sci 1057:50-63, 2005
97. Ross OA, Curran MD, Rea IM, et al: HLA haplotypes and TNF polymorphism do not associate with longevity in the Irish. Mech Ageing Dev 124:563-567, 2003
98. Carru C, Pes GM, Deiana L, et al: Association between the HFE mutations and longevity: A study in Sardinian population. Mech Ageing Dev 124:529-532, 2003
99. Caruso C, Candore G, Romano GC, et al: Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data. Mech Ageing Dev 122:445-462, 2001
100. Tyner SD, Venkatachalam S, Choi J, et al: p53 mutant mice that display early ageing-associated phenotypes. Nature 415:45-53, 2002
101. Kojima T, Nakahama K, Yamamoto K, et al: Age- and cell cycle-dependent changes in EPC-1/PEDF promoter activity in human diploid fibroblast-like (HDF) cells. Mol Cell Biochem 293:63-69, 2006
102. Gupta S, Pathak RU, Kanungo MS: DNA methylation induced changes in chromatin conformation of the promoter of the vitellogenin II gene of Japanese quail during aging. Gene 377:159-168, 2006
103. Lim CS: SIRT1: Tumor promoter or tumor suppressor? Med Hypotheses 67:341-344, 2006
104. Laux DE, Curran EM, Welshons WV, et al: Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas. Breast Cancer Res Treat 56:35-43, 1999
105. Salem CE, Markl ID, Bender CM, et al: PAX6 methylation and ectopic expression in human tumor cells. Int J Cancer 87:179-185, 2000
106. Jain PK: Epigenetics: The role of methylation in the mechanism of action of tumor suppressor genes. Ann N Y Acad Sci 983:71-83, 2003
107. Esteller M: DNA methylation and cancer therapy: New developments and expectations. Curr Opin Oncol 17:55-60, 2005
108. Espino PS, Drobic B, Dunn KL, et al: Histone modifications as a platform for cancer therapy. J Cell Biochem 94:1088-1102, 2005
109. Pompetti F, Pilla D, Giancola R: Cancer therapy: Switching off oncogenes. Bioessays 25:104-107, 2003
110. Jiricny J, Nystrom-Lahti M: Mismatch repair defects in cancer. Curr Opin Genet Dev 10:157-161, 2000
111. Rowley PT: Inherited susceptibility to colorectal cancer. Annu Rev Med 56:539-554, 2005
112. Narayan S, Roy D: Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer 2:41, 2003
113. Peltomaki P: Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 21:1174-1179, 2003
114. Jasin M: Homologous repair of DNA damage and tumorigenesis: The BRCA connection. Oncogene 21:8981-8993, 2002
115. Liu Y, West SC: Distinct functions of BRCA1 and BRCA2 in double-strand break repair. Breast Cancer Res 4:9-13, 2002
116. Irminger-Finger I, Jefford CE: Is there more to BARD1 than BRCA1? Nat Rev Cancer 6:382-391, 2006
117. de Boer J, Hoeijmakers JH: Cancer from the outside, aging from the inside: Mouse models to study the consequences of defective nucleotide excision repair. Biochimie 81:127-137, 1999
118. Andressoo JO, Mitchell JR, de Wit J, et al: An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria. Cancer Cell 10:121-132, 2006
119. de Boer J, Andressoo JO, de Wit J, et al: Premature aging in mice deficient in DNA repair and transcription. Science 296:1276-1279, 2002
120. Malumbres M, Barbacid M: Cell cycle kinases in cancer. Curr Opin Genet Dev 17:60-65, 2007
121. Carvajal RD, Tse A, Schwartz GK: Aurora kinases: New targets for cancer therapy. Clin Cancer Res 12:6869-6875, 2006
122. Gagos S, Irminger-Finger I: Chromosome instability in neoplasia: Chaotic roots to continuous growth. Int J Biochem Cell Biol 37:1014-1033, 2005
123. Wodarz D: Effect of stem cell turnover rates on protection against cancer and aging. J Theor Biol 245:449-458, 2007
124. Sell S: Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 51:1-28, 2004
125. Reya T, Morrison SJ, Clarke MF, et al: Stem cells, cancer, and cancer stem cells. Nature 414:105-111, 2001
126. Little MP, Boice JD Jr: Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res 151:218-224, 1999
127. Reynolds BA, Weiss S: Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175:1-13, 1996